story of the week
Endocrine Therapy Plus Entinostat or Placebo in HR+ Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group
J. Clin. Oncol 2021 Aug 06;[EPub Ahead of Print], RM Connolly, F Zhao, KD Miller, MJ Lee, RL Piekarz, KL Smith, UA Brown-Glaberman, JS Winn, BA Faller, AA Onitilo, ME Burkard, GT Budd, EG Levine, ME Royce, PA Kaufman, A Thomas, JB Trepel, AC Wolff, JA SparanoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.